About
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Technologies
REQORSA® Immunogene Therapy
GPX-002 and GPX-003
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
About
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Technologies
REQORSA® Immunogene Therapy
GPX-002 and GPX-003
ONCOPREX® Nanoparticle Delivery System
Programs
Oncology Combination Treatment Approach
Lung Cancer
Diabetes
Clinical Trials
Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy
Investors
Overview
Company Profile
Stock Information
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder FAQ
Downloads
Events
News
Press Releases
Blog Posts
Media Coverage
Videos
Email Alerts
Contact
© 2024 © 2020 Genprex Inc. All Rights Reserved.
Timeline
1
2
3
4
>
Search for:
Categories
Blog Posts
Media Coverage
Press Releases
Recent Posts
Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials
Genprex Announces Positive Clinical Study Updates from Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials in Lung Cancer
Genprex Granted Patent in Singapore for Reqorsa® Gene Therapy with PD-1 Antibodies to Treat Cancers
Archives
September 2024
August 2024
June 2024
May 2024
April 2024
March 2024
February 2024
January 2024
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
November 2021
September 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
October 2017
July 2017
April 2017
March 2017
January 2017
December 2016
November 2016
August 2016
May 2014
April 2012
September 2011
July 2011
June 2011
April 2011
May 2010
